Ophthalmology

Ophthalmology

Ophthalmology is the branch of medicine which deals with the diseases and surgery of the visual pathways, including the eye, brain, and areas surrounding the eye, such as the lacrimal system and eyelids Clinical Offerings

  1. General Ophthalmic Services
  2. Refractive Surgery
    1. Intralase – LASIK Wave front Method
  3. Cataract Surgery
    1. Phakoemulsification
  4. Glaucoma
    1. Glaucoma filtering surgery (trabeculectomy)
    2. Glaucoma non-penetrating surgery(deep sclerectomy)
    3. Glaucoma implants
    4. Glaucoma antimetabolite filtering surgery
    5. Combined glaucoma and cataract surgery
    6. Cyclocryotherapy
    7. Argon Laser trabeculoplasty
    8. YAG laser procedures
    9. Surgical bleb manipulation
    10. SLT Laser
  5. Oculoplastic
    1. Blepharoplasty
    2. Enucleation with hydroxy-apatite implant
    3. Dacrycystorhinostomy
  6. Retina and Vitreous
    1. Lasers- 532 nm 690 nm
    2. Vitrectomy surgery
    3. Scleral buckling
    4. Silicone oil implantation
  7. Corneal
    1. Anterior segment reconstruction
    2. Penetrating Keratoplasty with intraLase– (IntraLase-Enabled Keratoplasty)
    3. Excimer Laser Surgery
    4. Astigmatism Correction
    5. Complcated cataract surgery
    6. Correction of intraocular lens problems
    7. Combined procedures (Penetrating keratoplasty with glaucoma,cataract or vitreous surgery with keratoprosthesis)
  8. Keratoconus treatment
    1. Cross linking
    2. Topography guided excimer laser

INNOVATIVE TREATMENTS We have discovered innovative, vision-improving treatment for diseases of the retina and Severe Dry Eyes. We now have the opportunity to treat retinal diseases and Severe Dry Eyes in a way that was not previously possible. Our new treatments will have a positive impact on a large portion of the population. Specifically, New Treatments for:

  • Dry Macular Degeneration
  • Retinitis Pigmentosa
  • Diabetic Ischaemic Maculopathy
  • Branch Retinal Vein Occlusion
  • Severe Dry Eyes

We have a patent application number of the compound in EPO (European Patent Organisation) from September 2011. In 2012 an application has been made to the international PCT for the innovate treatment of retinal pathologies and severe dry eyes. In 2013 the Ophthalmos Eye and Laser centre is proceeding with multicentre clinical trials for the innovate treatment of retinal pathologies and severe dry eyes at ophthalmic clinics in Europe and America. The World Intellectual Property Organization published the patent application of Dr Tassos Georgiou on the 21/3/2013.